Skip to main content
Dermatology Reports logoLink to Dermatology Reports
. 2023 Aug 9;15(4):9777. doi: 10.4081/dr.2023.9777

Prevalence and risk factors for disability in leprosy patients in Indonesia during the post-elimination era

Paula M Samosir 1,, Presstisa Gifta Axelia 2, Firas F Alkaff 3,4, Sovia Salamah 4,5, Medhi Denisa Alinda 2
PMCID: PMC10848642  PMID: 38327586

Abstract

Leprosy has been nationally eliminated in Indonesia, but it continues to be a public health problem, with disability contributing to the disease burden. Disability caused by leprosy often results in stigmatization, leading to decreased quality of life. This was a retrospective cross-sectional study using secondary data from primary healthcare centers in one of the districts in the region with the highest number of leprosy patients in Indonesia. All leprosy patients between 2016-2022 were included. Among 189 leprosy patients (mean age 46 years old, 65.6% male), 19% had grade 1 disability and 29.6% had grade 2 disability. Duration of disease, nerve enlargements, leprosy reactions, and symmetric lesions were identified as risk factors for both grade 1 and 2 disability. Being male and having a positive smear test was associated with a higher risk of only grade 2 disability. Disability due to leprosy is still prevalent in the post-elimination era despite the decline in new leprosy cases. Improvement in early case detection and prevention of disability are still needed in the post-elimination era.

Key words: disability, epidemiology, Indonesia, leprosy, tropical disease

Introduction

Leprosy is a neglected tropical disease (NTD) caused by Mycobacterium leprae that continues to be a health problem in Indonesia. This infection primarily damages peripheral nerves and mucocutaneous tissues, which manifests as a loss of skin sensation and the development of deformities and disabilities as the disease progresses.1,2 Indonesia ranked third globally in leprosy cases, with incidence reaching more than 13,000 new cases by 2022.1-3 According to the Indonesian Ministry of Health, the prevalence rate of leprosy in Indonesia had decreased, but from 2001 to 2019 there had been an increasing trend of leprosy cases with grade 2 disabilities, with a proportion above 10%.4 Disability assessment in leprosy patients is a very important factor in the evaluation of the effectiveness of a leprosy elimination program. Gradual increases in grade 2 disability appear to be a sign of growing detection-detection delays, which itself is an indication of operational failure.5,6

Leprosy that is not treated immediately causes this disease to develop in a progressive direction causing damage to the skin, nerves, limbs, and eyes.6,7 In the absence of verifiable data, it has been estimated that 3-4 million people are living with visible impairments or deformities as a consequence of the disease.1 Disability in leprosy can cause broad problems and have an impact on education, and employment, and lead to social and economic problems.8 Disability caused by leprosy often results in stigmatization and discrimination, leading to decreased social participation and quality of life.9 Understanding the related risk factors would be helpful for preventing the physical disability associated with leprosy disease.10

East Java Province achieved elimination in 2016; however, East Java remains the province with the highest number of leprosy patients in the country.11,12 In 2021, a total of 1694 newly diagnosed leprosy cases were identified in East Java, and 9.76% of cases had been assessed with grade 2 disability (G2D) at the time of diagnosis. The proportion of G2D in East Java still needs attention because even though it has decreased every year, the value still has not reached the national target of less than 5%.11 Previous studies in India discovered that the prevalence of G2D among new leprosy cases was detected higher in rural areas than in urban areas.13,14 Majority of the leprosy patients in Indonesia are spread in rural areas and managed in primary health care.11

A number of studies had been conducted about disabilities in leprosy in referral hospitals,15-17 but very few from the primary care settings. Therefore, this study aims to describe the profile and explore the risk factors of disability in leprosy patients in primary healthcare settings.

Material and Methods

This cross-sectional retrospective study was conducted in Mojokerto District, one of the rural districts in the East Java province, Indonesia. Data on all leprosy patients between 2016 and 2022 were collected from the medical records of all primary public healthcare centers in the district. Exclusion criteria in this study were leprosy patients with missing data regarding the disability status or who had prior physical disabilities that were not caused by leprosy. The assessment of the degree of disability was performed according to the current classification system of WHO, using the following criteria: grade 0 disability indicates no loss of sensitivity or visible deformity; grade 1 disability (G1D) is defined as loss of sensitivity without visible deformity; and grade 2 disability (G2D) is defined by as loss of sensitivity with the presence of visible deformity.6 This study followed the declaration of Helsinki and was approved by the Department of Health of Mojokerto District and City (072/1453/416-206/2022).

Histogram and Quantile-Quantile plot were used to evaluate the data distribution. Data were presented as mean ± standard deviation (SD) for normally distributed data and as frequency (valid percentage) for categorical data. Comparison between groups was tested with a chi-square test and independent t-test as appropriate. To identify the risk factors associated with disability, multinomial logistic regression models were used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs). For all analyses, p<0.05 was considered statistically significant. All statistical analyses were done using SPSS for Windows version 24.0 (IBM Corp., Armonk, New York) and R version 4.2.1 (R Foundation for Statistical Computing, Vienna, Austria).

Results

There were 189 leprosy patients included in this study. Looking at the number of patients each year, there was a decreasing trend in the number of patients from 2016 to 2022 (Figure 1). The median age was 46±15 years, and there were more male patients. The type of lepra in almost all of the patients was MB type. The majority of the patients were diagnosed in less than two years after developed the disease. Disability was presented in 92 (48.7%) patients. Stratified based on its grade, 36 (19%) had G1D, and 56 (29.6%) patients had G2D. From this study, almost the entire patients (86.8%) were discovered from passive case findings. More detailed baseline characteristics of the study population are presented in Table 1.

Stratified based on the disability grade, all patients in G1D and G2D groups had MB type of leprosy. There were significantly more male patients in the G2D group compared to G1D or nondisability group. Furthermore, the presence of leprosy reaction, longer disease duration, and history of relapse were more prevalent across the increasing grade of disability. In addition to that, the number of nerve enlargements also increased across the increasing grade of disability (Table 2).

Zooming in to patients only with disability, the majority of the patients had disability at the time of diagnosis, whereas 8 (8.7%) patients and 4 (4.3%) patients had disability during treatment and after treatment, respectively. There was no significant difference in the time of disability between patients with G1D and G2D (p=0.7). The most common site of disabilities was on the feet 66 (71.7%) in both patients with G1D and G2D (Table 3). Hypoesthesia/anesthesia was the most common type of G1D found. The most frequent visible disability in the G2D group was foot ulcer. More detailed types of disabilities in the study population are presented in Table 4.

Table 1.

General characteristics of the study population.

Characteristics No. (%) [total=189]
Disability
   No disability 97 (51.4)
   Grade 1 disability 36(19)
   Grade 2 disability 56 (29.6)
Age in years, mean ± standard deviation 46±15
Sex
   Female 65 (34.4)
   Male 124 (65.6)
Types of Leprae
   Multibacillary 186 (98.4)
   Paucibacillary 3 (1.6)
Disease duration
   <2 years 126 (66.7)
   ≥2 years 63 (33.3)
Education level
   Up to primary school graduates 94 (49.7)
   At least secondary school graduates 95 (50.3)
Occupation
   Unemployed 50 (26.5)
   Student 11 (5.8)
   Farmer 54 (28.6)
   Private employee 45 (23.8)
   Others 29 (15.3)

Figure 1.

Figure 1.

Distribution of new patients in Mojokerto District across the study period.

Nerve enlargements, regardless of whether it was 1 nerve or 2 nerves, were the strongest risk factors for developing G1D (OR=12.41, p<0.001 for 1 nerve and OR=98.0, p<0.001 for 2 nerves) or G2D (OR=31.36, p=0.001 for 1 nerve and OR=906.50, p<0.001 for 2 nerves). Furthermore, those with leprosy reaction, suffered from leprae for more than 2 years, and had symmetric lesion distribution were also associated with a higher risk of having G1D and G2D. In addition to that, being male and had positive smear result were associated with a higher risk of having G2D (Table 5).

Table 2.

Sociodemographic and clinical characteristics of the study population grouped based on the disability grades.

Characteristics [total = 97] No disability, n (%) [total = 36] Grade 1, n (%) [total = 56] Grade 2, n (%) p
Age in years, mean ± SD 46±15 47±15 46±16 0.9
Sex 0.022
   Female 40 (41.2) 14 (40.5) 11 (19.6)
   Male 57 (58.8) 22 (59.5) 45 (80.4)
Leprosy reaction <0.001
   No 89 (91.8) 23 (64.9) 33 (58.9)
   Yes 8 (8.2) 13 (35.1) 23 (41.1)
Types of Leprae 0.2
   Multibacillary 94 (96.9) 36(100) 56(100)
   Paucibacillary 3 (3.1) 0 (0.0) 0 (0.0)
Disease duration <0.001
   <2 years 91 (93.8) 23 (64.9) 11 (19.6)
   ≥2 years 6 (6.2) 13 (35.1) 45 (80.4)
Education level 0.1
   Up to primary school graduates 42 (43.3) 20 (56.8) 32 (57.1)
   At least secondary school graduates 55 (56.7) 16 (43.2) 24 (42.9)
Occupation 0.3
   Unemployed 33 (34.0) 10 (27.0) 8 (14.3)
   Student 4 (4.1) 2 (5.4) 5 (8.9)
   Farmer 22 (22.7) 11 (29.7) 21 (37.5)
   Private employee 23 (23.7) 8 (21.6) 14 (25.0)
   Others 15 (15.5) 6 (16.2) 8 (14.3)
History of relapse 0.010
   No 97(100) 35 (97.3) 51 (91.1)
   Yes 0 (0.0) 1 (2.7) 5 (8.9)
History as defaulters 0.034
   No 94 (96.9) 36(100) 50 (89.3)
   Yes 3 (3.1) 0 (0.0) 6 (10.7)
Case detection mode 0.4
   Passive findings 81 (83.3) 32 (89.2) 51 (91.1)
   Active findings 16 (16.7) 4 (10.8) 5 (8.9)
Contact history 0.099
   No 62 (61.1) 26 (72.2) 28 (50.0)
   Yes 35 (38.9) 10 (27.8) 28 (50.0)
Nerve enlargement <0.001
   No 49 (64.5) 3 (8.8) 1 (1.9)
   1 nerve 25 (32.9) 19 (55.9) 16 (29.6)
   2 nerves 2 (2.6) 12 (35.3) 37 (68.5)
Lesion distribution 0.010
   Asymmetry 31 (36.5) 5 (13.9) 10 (18.2)
   Symmetry 54 (63.5) 31 (86.1) 45 (81.8)
Types of lesion 0.2
   Macule 78 (91.8) 29 (80.6) 48 (87.3)
   Plaque 7 (8.2) 6 (16.7) 7 (12.7)
   Nodule 0 (0.0) 1 (2.8) 0 (0.0)
Smear results 0.055
   Negative 17 (28.3) 4 (17.4) 4 (9.3)
   Positive 43 (71.7) 19 (82.6) 39 (90.7)

Contact history is missing in 7 patients, nerve enlargement is missing in 25 patients, lesion distribution and types of lesions is both missing in 13 patients, and smear results is missing in 63 patients. Values in italics are statistically significant.

Discussion

Our study showed that in the post-elimination era, new patients were still discovered every year, albeit the trend of the discovery of new patients declined every year. This study revealed that 48.7% of the leprosy patients studied had disability. G1D and G2D accounted for 19% and 29.6% of the total sample of patients, respectively. The logistic regression analysis revealed that the risk factors associated with G1D and G2D were found to be nerve enlargements, leprosy reactions, duration of disease for more than 2 years, and symmetric lesion distribution. Being male and having a positive smear result was associated with a higher risk of having G2D. The disability was not significantly related to the type of leprosy, education level, history of relapse, history of defaulters, case detection mode, contact history, or type of lesion.

frequently lifelong negative impact on the patient’s quality of life, including social exclusion, stigma, and discrimination.7,9 The most frequent visible disability (G2D) was foot ulcer and followed by claw hand. This is similar to studies in tertiary medical centers that discovered foot ulcers to be the most common deformity.16,17 Claw hand was found to be the most common deformity in the upper limb.18 Leprosy patients are more likely to develop neuropathic ulcers due to delayed diagnosis, inadequate therapy, and failure to manage leprosy reactions.19 A higher frequency of the posterior tibial and fibular nerve involvement in leprosy is also associated with an increased prevalence of foot ulcer deformities. 20 Grade 2 disabilities do not occur spontaneously; early diagnosis of grade 1 disability is necessary for disability control and mitigation.18 The majority of the patients had developed disability before the treatment started, with the duration of disease being less than 2 years. This is similar to previous studies in Bangladesh and Western India, that also found a higher amount of G2D, reflecting a failure of the leprosy case detection.14,18 Besides as indicator of delayed leprosy detection, G2D indirectly provides information on factors that affect case detection, such as community awareness about leprosy, the capacity of health staff to recognize early signs and symptoms, and, to some extent, the quality of the leprosy health services themselves.1,21 After the completion of leprosyelimination programs, numerous investigations found that delays had been caused by health care workers’ lack of practical expertise, as well as their lack of interest and commitment to leprosy.7 In addition, patients with leprosy frequently delay seeking treatment because they attempt to conceal their lesions due to the social stigma attached to leprosy.7-9 These findings suggest the need for improvement in early case detection in the post-elimination era to prevent leprosy burden in the future.

Most of our leprosy patients were discovered from passive case findings, in line with other studies conducted in post-elimination areas.18,22 In our analysis, statistically significant differences were not found between the active and passive detection modes with regard to the presence of disabilities, but further efforts focusing on active case findings are crucial for improving leprosy control programs. Increasing active case detection succeeded in improving the early detection of leprosy cases and resulted in a declining trend of annual proportion of G2D among new cases in Shandong province, China.23 Another study about active casefinding had verified that there were a large number of undetected cases in the community which revealed the real burden of leprosy. 14,23

Table 3.

Distribution of the disability grade based on the disability location.

Location Grade Cases with disability, n (%) [total = 92]
Eye No disability 82 (89.2)
Grade 1 4 (4.3)
Grade 2 6 (6.5)
Hand No disability 41(44.6)
Grade 1 23(25)
Grade 2 28 (30.4)
Feet No disability 26 (28.3)
Grade 1 34 (36.9)
Grade 2 32 (34.8)

Table 4.

Types of disability.

Location Types of disability Cases, n (%) [total = 92]
Grade 1 disability Hypoesthesia/anesthesia 30(25)
Muscle weakness 17 (14.2)
Decreased vision 5 (4.2)
Grade 2 disability Wrists drop 2(1.7)
Claw hand 17 (14.2)
Hand absorption 1 (0.8)
Hand ulcer 1 (0.8)
Foot drop 13 (10.8)
Claw toes 4 (3.3)
Foot ulcer 18(15)
Contracture 3 (2.5)
Mutilation 2 (1.7)
Lagophthalmos 4 (3.3)
Madarosis 2 (1.7)
Saddle nose 1 (0.8)

According to our study, men significantly raise the risk of G2D. This study is comparable to one in India that revealed a higher rate of disability to be related to male sex. It can be explained by the fact that males are more likely to sustain trauma as a result of strenuous physical activity.19Our study also found that positive smear results were associated with a higher risk of having G2D. A cohort study by Quilter et al. found slit skin smear positivity as a dominant risk factor for leprosy development but not directly associated with disability in leprosy.24

Higher educational level has been considered as a protective factor for the development of disability in leprosy as well as a determining factor for disease improvement.25 However, our study discovered that education level was not associated with disability in leprosy. The correlation between the type of leprosy and disability in this study was not significant, similar to a study conducted in a tertiary hospital in Indonesia.14 While another study conducted in India showed that disability in MB patients was more significant than in PB patients.26

In line with previous studies,22,27,28 the presence of a leprosy reaction was associated with G1D and G2D in leprosy. Leprosy reactions can occur prior to, during, and after treatment with multi-drug therapy, therefore disability assessment needs to be continued after completion of the treatment to early detect and prevent the progression of disabilities in individuals exposed to the risk of disabilities.6,18 Our analysis showed that nerve enlargements were the strongest risk factors for developing physical disability. Other studies carried out in Brazil also found that the number of affected nerves as the main factor associated with the development of disability.25,27

Table 5.

Multinominal logistic regression.

Characteristics Grade 1 Grade 2
OR (95%CI) p OR (95%CI) p
Age 1.00 (0.98-1.03) 0.8 1.00 (0.98-1.02) 0.8
Sex
   Female Ref Ref Ref Ref
   Male 1.10 (0.50-2.41) 0.8 2.80 (1.29-6.08) 0.009
Leprosy reaction
   No Ref Ref Ref Ref
   Yes 6.29 (2.33-16.97) <0.001 7.67 (3.12-18.83) <0.001
Types of Leprae
   Multibacillary Ref Ref Ref Ref
   Paucibacillary 62026.4 (0-∞) 1.0 42116.47 (0-∞) 1.0
Disease duration
   < 2 years Ref Ref Ref Ref
   ≥ 2 years 7.58 (2.58-22.29) <0.001 74.45 (24.40-227.23) <0.001
Education level
   Up to primary school graduates Ref Ref Ref Ref
   At least secondary school graduates 0.61 (0.28-1.32) 0.2 0.56 (0.29-1.09) 0.087
History of relapse, n (%)
   No Ref Ref Ref Ref
   Yes 15957367.07 (0-∞) 1.0 29461385.02 (0-∞) 1.0
History as defaulter, n (%)
   No Ref Ref Ref Ref
   Yes 0.00 (0-∞) 1.0 3.72 (0.89-15.51) 0.071
Case detection mode, n (%)
   Passive findings Ref Ref Ref Ref
   Active findings 0.63 (0.20-2.04) 0.4 0.49 (0.17-1.42) 0.2
Contact history, n (%)
   No Ref Ref Ref Ref
   Yes 0.60 (0.26-1.40) 0.2 1.57 (0.80-3.08) 0.2
Nerve enlargement, n (%)
   0 nerve Ref Ref Ref Ref
   1 nerve 12.41 (3.35-45.98) <0.001 31.36 (3.93-250.22) 0.001
   2 nerves 98.00 (14.70-653.44) <0.001 906.50 (79.17-10379.71) <0.001
Lesion distribution, n (%)
   Asymmetry Ref Ref Ref Ref
   Symmetry 3.56 (1.25-10.10) 0.017 2.58 (1.14-5.84) 0.022
Types of lesion, n (%)
   Macule Ref Ref Ref Ref
   Plaque 2.31 (0.71-7.43) 0.2 1.62 (0.54-4.92) 0.4
   Nodule 15486531.14 (0-∞) 1.0 - -
Smear results, n (%)
   Negative Ref Ref Ref Ref
   Positive 1.88 (0.56-6.33) 0.3 3.85 (1.19-12.45) 0.024

Contact history is missing in 7 patients, nerve enlargement is missing in 25 patients, lesion distribution and types of lesions is both missing in 13 patients, and smear results is missing in 63 patients.

Furthermore, those who suffered the disease for more than 2 years before the diagnosis were also associated with a higher risk of having G1D and G2D. Other retrospective studies also discovered patients with a duration of symptoms greater than 12 months and 24 months were more likely to develop disability.16,29 The longer the duration of symptoms the higher the likelihood of developing nerve damage and sensory loss, both of which subsequently lead to disability.6,29 Symmetric lesion distribution was also found to be a risk factor for developing a disability in leprosy. Previous studies have shown the risk of disability was lower for patients whose lesion distribution is asymmetrical.30

These findings provide information that can be integrated in the future, to identify leprosy patients at early risk of physical disabilities, monitor the progression of this disease more closely, and therefore prevent any further deformity. Long-term follow-up is necessary to monitor factors associated with the development of disabilities, as is the provision of interventions promoting selfcare, appropriate management of early disability, and the availability of rehabilitation services.1,5,18 Our study discovered even after elimination, the number of cases with disability is still high, therefore the national leprosy control program should investigate the leprosy case detection system and work on improving early case detection. A comprehensive effort to enhance early case detection is needed, including health promotion among the community, healthcare personnel training, and increasing active casefinding activities.1,6,23

There were several limitations to this study. This study was a time-bound, cross-sectional study. The data were collected from manual medical records, leading to a loss of some information. A multicenter study is warranted to confirm this study’s findings.

Conclusions

This study found that, despite a decline in new leprosy cases, the disability rate is still prevalent, with G2D predominance. Most patients were detected by passive case findings, developed disability before treatment, and had a duration of disease less than 2 years. These results suggest that delayed case detection is still an issue that will lead to leprosy burdens in the future. Several risk factors associated with disability have been identified and might assist in early identification and careful follow-up. Further improvement in the early detection and prevention of disability is still needed in the post-elimination era through health promotion, healthcare personnel training, and active case-finding activities.

Acknowledgments

The authors would like to thank all Leprosy health workers in the primary public health center in Mojokerto for providing the data used in this study.

References

  • 1.World Health Organization. Towards zero leprosy global leprosy (hansen’s disease) strategy 2021-2030. World Health Organization, New Delhi: 2021. pp 5-25. [Google Scholar]
  • 2.Indonesian Ministry of Health. Mari bersama hapuskan stigma dan diskriminasi kusta di masyarakat. 2022. Available from: http://p2p.kemkes.go.id/mari-bersama-hapuskan-stigma-dandiskriminasi-kusta-di-masyarakat/ Accessed on January 20, 2023. [Google Scholar]
  • 3.Kang S, Amagai M, Bruckner A, et al. Fitzpatrick’s dermatology. 9th ed. New York: McGraw Hill; 2019: pp 2892-924. [Google Scholar]
  • 4.Indonesian Ministry of Health. Peraturan Menteri Kesehatan Republik Indonesia Nomor 11 tahun 2019 tentang Penanggulangan Kusta. Indonesia. Available from: http://hukor.kemkes.go.id/uploads/produk_hukum/PMK_No__11_Th_2019_ttg_Penanggulangan_Kusta.pdf Accessed on January 22, 2023. [Google Scholar]
  • 5.Mowla MR, Ara S, Tripura S. Leprosy profiles in post-elimination stage: a tertiary care hospital experience. Int J Dermatol 2015;54:1407-13. [DOI] [PubMed] [Google Scholar]
  • 6.World Health Organization. Guidelines for the diagnosis, treatment and prevention of leprosy. New Delhi: World Health Organization, Regional Office for South-East Asia; 2018. [Google Scholar]
  • 7.Dharmawan Y, Fuady A, Korfage I, Richardus JH. Individual and community factors determining delayed leprosy case detection: a systematic review. PLoS Negl Trop Dis 2021;15:1-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Urgesa K, de Bruijne ND, Bobosha K, et al. Prolonged delays in leprosy case detection in a leprosy hot spot setting in Eastern Ethiopia. PLoS Negl Trop Dis 2022;16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Menaldi SL, Harini M, Nelfidayani N, et al. Functional activity limitation of leprosy cases in an endemic area in Indonesia and recommendations for integrated participation program in society. PLoS Negl Trop Dis 2022;16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Brakel WH, Sihombing B, Djarir H, et al. Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination. Glob Health Action 2012;5:1-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Indonesian Ministry of Health. Leprosy data validation report 2021. Ministry of Health, Directorate General of Diseases Prevention and Control; 2022. Available from: https://p2pm.kemkes.go.id/storage/informasi-publik/content/informasi-publik_18_20220718073519.pdf Accessed on January 26, 2023. [Google Scholar]
  • 12.Adriaty D, Prakoeswa CRS, Iswahyudi, et al. Leprosy transmission in endemic and non-endemic areas based on the profile of antibody response of PGL-1 and PCR detection of Mycobacterium leprae DNA from nasal swab among healthy children of East Java, Indonesia. Infect Dis Rep 2020;12:109-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kumar A, Husain S, Murthy BN. Burden of leprosy-related disability: results of a population survey in two states in India. Lepr Rev 2018;353-61. [Google Scholar]
  • 14.Shetty VP, Thakar UH, D’Souza E, et al. Detection of previously undetected leprosy cases in a defined rural and urban area of Maharashtra, Western India. Lepr Rev 2009;80:22-33. [PubMed] [Google Scholar]
  • 15.Prakoeswa CRS, Lubis RS, Anum Q, et al. Epidemiology of leprosy in Indonesia: a retrospective study. Berk Ilmu Kesehat Kulit dan Kelamin 2022;34:29-35. [Google Scholar]
  • 16.Geani S, Rahmadewi Astindari, et al. Risk factors for disability in leprosy patients: a cross-sectional study. Bali Med J 2022;11:197-201. [Google Scholar]
  • 17.Rathod SP, Jagati A, Chowdhary P. Disabilities in leprosy: an open, retrospective analyses of institutional records. An Bras Dermatol 2020;95:52-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Mowla MR, Angkur DM, Hasan Z, et al. Leprosy patients with deformities at post-elimination stage: The Bangladesh experience. Skin Health Dis 2021;1:1-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Reyila V, Betsy A, Riyaz N, et al. Clinico-epidemiological study of disability due to leprosy at the time of diagnosis among patients attending a tertiary care institution. Indian J Dermatol 2019;64:106-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Batista KT, Monteiro GB, Y-Schwartzman UP, et al. Treatment of leprosy-induced plantar ulcers. Rev Brasil Cirurgia Plastica 2019;34:497-503. [Google Scholar]
  • 21.World Health Organization. Global leprosy strategy 2016-2020 accelerating towards a leprosy-free world. New Delhi: World Health Organization, Regional Office for South-East Asia; 2016. [Google Scholar]
  • 22.Chen X, Liu HB, Shui TJ, Zha S. Risk factors for physical disability in patients with leprosy disease in Yunnan, China: evidence from a retrospective observational study. PLoS Negl Trop Dis 2021;15:1-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Chu T, Liu D, Huai P, et al. Comprehensive measures succeeded in improving early detection of leprosy cases in post-elimination era: Experience from Shandong Province, China. PLoS Negl Trop Dis 2020;14:1-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Quilter EEV, Butlin CR, Singh S, et al. Patients with skin smear positive leprosy in Bangladesh are the main risk factor for leprosy development: 21-year follow-up in the household contact study (Cocoa). PLoS Negl Trop Dis 2020;14:1-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Moschioni C, Antunes CMF, Grossi MAF, Lambertucci JR. Risk factors for physical disability at diagnosis of 19,283 new cases of leprosy. Rev Soc Bras Med Trop 2010;43:19-22. [DOI] [PubMed] [Google Scholar]
  • 26.Sarkar J, Dasgupta A, Dutt D. Disability among new leprosy patients, an issue of concern: An institution based study in an endemic district for leprosy in the state of West Bengal, India. Indian J Dermatol Venereol Leprol 2012;78:328-34. [DOI] [PubMed] [Google Scholar]
  • 27.Santos VS, Mayara A, Matos SD, et al. Clinical variables associated with disability in leprosy cases in northeast Brazil. J Infect Dev Ctries 2015;9:232-8. [DOI] [PubMed] [Google Scholar]
  • 28.Raposo MT, Reis MC, Caminha AV, et al. Grade 2 disabilities in leprosy patients from Brazil: need for follow-up after completion of multidrug therapy. PLoS Negl Trop Dis 2018;38:1-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Shumet T, Demissie M, Bekele Y. Prevalence of disability and associated factors among registered leprosy patients in all africa Tb and Leprosy Rehabilitation and Training Centre (ALERT), Addis Ababa, Ethiopia. Ethiop J Health Sci 2015;25:313-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Mulugeta SS, Maseresha BM, Wassihun SG, Moyehodie YA. Risk factors for disability upgrading among leprosy patients during treatment: multilevel modelling analysis. SAGE Open Nurs 2022;8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Dermatology Reports are provided here courtesy of PAGEPress

RESOURCES